Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
It may also be prescribed for certain cobalt deficiencies, certain pancreatic diseases or intestinal malabsorption conditions
The theory is elegant: target fat cells directly by activating the same pathway that GH uses to stimulate fat release, without elevated IGF-1 or blood sugar concerns
Oral AOD 9604 formulations exist but have significantly lower bioavailability than subcutaneous injection
Therefore, inhibiting NNMT with 5-Amino-1MQ may represent a novel approach to weight loss intervention
This is more common in women than men
As a research peptide, AOD-9604 is not manufactured under the same regulatory oversight as pharmaceutical products
